Human Continuum

📍 New York, United States👥 4 employees💰 Last funded Jun 2026
Biotechnology Research🌐 hcontinuum.com
Website LinkedIn
Pioneering the Future of Longevity Care through the clinical advancement of exosome technology. Our flagship product delivers a standardized, cell-free biologic enriched in regenerative signals aimed at promoting systemic rejuvenation, reducing inflammation, and optimizing cellular health, positioning it as a cornerstone of the emerging longevity market.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Human Continuum?
Human Continuum has 1 investors on record on gritt.io.
When did Human Continuum last raise funding?
The most recent investment in Human Continuum recorded on gritt.io was in June 2026.
What industry is Human Continuum in?
Human Continuum operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Human Continuum based?
Human Continuum is headquartered in New York, United States.